Delivery Order SPE2DB24D2100-SPE2DB25FBGGT
- Not listed
- The U.S. Defense Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Prevymis 480 mg tablets in quantities of seven tablets, valued at $4,719.34. The delivery order, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a non-competitive award under the company's existing contract vehicle. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. Prevymis...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Prevymis 480 mg tablets (7-count packages) valued at $4,719.34. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 23, 2025, with performance at the contractor's corporate headquarters in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Prevymis 480 mg tablets (7-count packaging) with a ceiling value of $4,719.34. This competitively awarded, non-set-aside contract is structured as a firm fixed-price delivery order and is scheduled for ultimate completion by August 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $4,719.34 delivery order to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (7-count package) on August 22, 2025, with completion scheduled for September 15, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Prevymis (letermovir) 120 mg pellet packets in quantities of 30 units. The contract, valued at $5,599.72, is structured as a firm fixed price delivery order with an ultimate completion date of September 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Prevymis 480 mg tablets in seven-tablet packages, with a contract ceiling value of $9,438.70 and a firm fixed price structure. This non-set-aside delivery order is scheduled for completion by September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's ongoing...
- The Defense Logistics Agency awarded a $9,438.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (quantity 7) on September 3, 2025, with an ultimate completion date of September 24, 2025. This non-set-aside competitive award is performed at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued...
- The Defense Logistics Agency awarded a delivery order valued at $4,719.34 to AmerisourceBergen Drug Corp for the supply of Prevymis 480 mg tablets (quantity 7) on August 19, 2025. This is a firm fixed price delivery order with an ultimate completion date of September 10, 2025 and no set-aside designation, indicating competitive award. The order will be fulfilled from the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a task under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of PREVYMIS (letermovir) 480 mg tablets in quantities of seven units. This is a competitively awarded, firm fixed-price delivery order with a ceiling value of $4,719.34, with an ultimate completion date of October 1, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,719.34 to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (7-count packages) on August 21, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price contract is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBGGTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Prevymis 480 mg tablets (7-count) with a ceiling value of $9,438.70. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is set for ultimate completion by October 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Prevymis is an antiviral medication used primarily for cytomegalovirus prophylaxis in immunocompromised patients, particularly transplant recipients. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement extending through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, maintains a significant role in federal medical procurement through the Defense Logistics Agency's Medical Supply Chain, fulfilling critical pharmaceutical needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's extensive portfolio of federal contracts demonstrates consistent capability to deliver diverse pharmaceutical products, from specialty medications to vaccines and medical supplies, across multiple therapeutic domains supporting military and veteran healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 9/10/25 |